Low-Risk Versus High-Risk AML

https://vimeo.com/825225958 How is AML risk determined, and how does it affect treatment options? Dr. Ann-Kathrin Eisfeld defines low-risk and high-risk AML and explains how this classification may predict disease response…

What Is the Purpose of AML Genetic Testing?

https://vimeo.com/820013032 How is genetic testing for AML administered, and what is the purpose? Dr. Sanam Loghavi explains the methods of genetic testing and the function of each method. Dr. Sanam…

Does Maintenance Therapy Have a Role in AML Care?

https://vimeo.com/777492990 Acute myeloid leukemia (AML) expert Dr. Farhad Ravandi-Kashani discusses the role of new and developing maintenance therapies that may improve remission and how this treatment phase may fit into…

Advances in AML Research | Where Do Clinical Trials Fit In?

https://vimeo.com/777492766 How do clinical trials advance acute myeloid leukemia (AML) research? Dr. Farhad Ravandi-Kashani discusses newer AML treatments that have changed the landscape of care and how patient trial participation…

How Does the Presence of Molecular Markers Affect AML Care?

https://vimeo.com/777492887 Dr. Farhad Ravandi-Kashani reviews how the presence of gene mutations can influence acute myeloid leukemia (AML) treatment choices and discusses new molecular markers being researched for future AML care….

Share On:

Facebook
Twitter
LinkedIn